Leticia Cazares
Researcher
Also affiliated: University of California, Los Angeles (2023–2025)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Leticia Cazares' research focuses on understanding barriers and facilitators to interventions aimed at reducing risky drug use, particularly within primary care settings. Her work has investigated the experiences of pregnant individuals using cannabis, with a specific emphasis on racial and ethnic disparities. Cazares has examined implementation challenges for Screening, Brief Intervention, and Referral to Treatment (SBIRT) programs, especially concerning monolinugal Spanish-speaking patients during the COVID-19 pandemic. She has also studied common barriers to cannabis use reduction among adult primary care patients in Los Angeles County.
Metrics
- h-index: 1
- Publications: 5
- Citations: 13
Selected Publications
-
Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study (2025)
Collaboration Network
Top Collaborators
- Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study
- Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study
- Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study
- Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study
- Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study
Similar Researchers
Based on overlapping research topics